Condition: Eczema · Allergy · Sponsor: The University of New South Wales
The LaCE study is a double-blind, randomised, placebo-controlled trial examining the effectiveness of the probiotic Lactobacillus paracasei LPB27 in treating eczema in young children.
This description comes directly from the study's public registry record.
Keith CY Ooi · 9382 1752 · keith.ooi@unsw.edu.au
Jessica Halim · 9382 1752 · lacestudy_SCH@unsw.edu.au
Always discuss trial participation with your own doctor first.
| Sydney Children's Hospital | Randwick, New South Wales, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06584552